Karyopharm Therapeutics Inc. buy Royal Bank of Canada
Start price
03.11.23
/
50%
€0.84
Target price
03.11.24
€2.80
Performance (%)
-11.46%
Price
19.08.24
€0.74
Summary
This prediction is currently active. The price of Karyopharm Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.46%. This prediction currently runs until 03.11.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Karyopharm Therapeutics Inc. | -1.930% | -1.930% |
iShares Core DAX® | 1.665% | 1.692% |
iShares Nasdaq 100 | -0.475% | 1.483% |
iShares Nikkei 225® | 2.620% | 4.475% |
iShares S&P 500 | -0.091% | 1.099% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) had its price target lowered by analysts at Royal Bank of Canada from $4.00 to $3.00. They now have an "outperform" rating on the stock.
Ratings data for KPTI provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.72
07.08.24
07.08.24
€2.75
07.08.25
07.08.25
-3.40%
19.08.24
19.08.24
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.67
03.08.23
03.08.23
€3.65
03.08.24
03.08.24
-54.66%
04.08.24
04.08.24